ArticleCancer reports (Hoboken, N.J.)2021

Pretreatment neutrophil-to-lymphocyte ratio as a potential prognostic biomarker for newly diagnosed patients with metastatic castration-sensitive prostate cancer.

Samer Salah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.